NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aptadel Therapeutics

Aptadel Therapeutics

Private
BarcelonaHealthcare & Life Scienceshttps://aptadeltx.com/

Last Round

VC Round

Mar 24, 2026

Total Funding Raised

$2.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Aptadel Therapeutics is a drug discovery company developing an RNA-based platform of targeted therapy to treat cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

Aptamer-drug ConjugateApDCEwing's sarcomaRNA aptamerstargeted cancer therapyRNA therapeuticspediatric oncologyrare disease therapyorphan drug developmentdrug delivery platformanti-metastaticprecision medicinepreclinical biotechRhabdomyosarcomacancer diagnostic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aptadel Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Aptadel Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aptadel Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 24, 2026
GrantFeb 11, 2025
SeedJan 21, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Gisela Lorente

Chief Executive Officer

Executive Team

Aptadel Therapeutics Investors

Notable investors and investment history

Aptadel Therapeutics investors
InvestorRounds
Newsight Tech AngelsVC Round
Little Warrior FoundationVC Round, Grant
Fundación Alba PérezSeed
Chasing ScienceSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 43% MoM.

  • Apr 22, 2026

    Monthly visitors increased 180% MoM, reaching 829.

View all signals

Aptadel Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aptadel Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aptadel Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range10
Year Founded2020
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.